Kaposi’s sarcoma regression after long term treatment of m-TOR inhibitors and cancellation of immunosuppressive therapy in patient after kidney transplantation
https://doi.org/10.15825/1995-1191-2019-2-121-124
Abstract
A case of observation of a patient who developed Kaposi’s sarcoma after kidney transplantation is presented. For the purpose of its treatment, conversion from tacrolimus to everolimus, courses of administration of prospidin were applied, in General, the intensity of immunosuppressive therapy was reduced. Stable remission was achieved only after removal of the renal transplant and complete withdrawal of immunosuppressive therapy.
About the Authors
A. D. Sapozhnikov
Volgograd state medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Sapozhnikov Arkady Davidovich
86, General Karbishev Str., Volzhsky city, Volgograd reg., 404120, Tel. (8443) 27-44-77
A. D. Perlina
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
I. N. Dymkov
Volgograd state medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
References
1. Vatazin AV, Molochkov VA, Kazance-va IA, Shcherbakova EO, Prokopenko EI, Pasov SA i dr. Sarkoma Kaposhi u bol’nyh posle transplantacii pochki (opyt odnogo centra). Nefrologiya i dializ. 1999; 1 (2, 3): 155-163. [In Russ. English abstract].
2. Cahoon EK, Linet MS, Clarke CA, Pawlish KS, Engels EA, Pfeiffer RM. Risk of Kaposi sarcoma after solid organ transplantation in the United States. Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31735.
3. Gorsane I, Bacha MM, Ezzedine A, Amri N et al. Post Kidney Transplantation Kaposi’s Sarcoma: the Experience of a Mediterranean North African Center. Clin. Transplant. 2016 Jan 19. doi: 10.1111/ctr.12694.
4. Fritzsche FR, Tutic M, Opitz I, Hunziker R, Kristiansen G, Montani M. Pulmonary Kaposi’s sarcoma after heart transplantation: a case report. J Med Case Rep. 2010 Jul 5; 4: 206.
5. Abalo-Lojo JM, Abdulkader-Nallib I, Perez LM, Gonzalez F. Eyelid Kaposi Sarcoma in an HIV-negative Patient. Indian J Ophthalmol. 2018 Jun; 66 (6): 854-855.
6. Smith A, Niu W, Desai A. The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Postrenal Transplantation Patients. Cureus. 2017 Aug 13; 9 (8): e1564.
7. Moosa MR. Kaposi’s sarcoma in kidney transplant recipients: a 23-year experience. QJM. 2005 Mar; 98 (3): 205-214.
8. Bohelay G, Arzouk N, Levy P, Rabate C, Le Cleach L, Barete S et al. Skin and Organ Transplantation Group of the French Society of Dermatology. Outcome of second kidney transplantation in patients with previous posttransplantation Kaposi’s sarcoma: A French retrospective study. Clin Transplant. 2017 Nov; 31 (11).
Review
For citations:
Sapozhnikov A.D., Perlina A.D., Dymkov I.N. Kaposi’s sarcoma regression after long term treatment of m-TOR inhibitors and cancellation of immunosuppressive therapy in patient after kidney transplantation. Russian Journal of Transplantology and Artificial Organs. 2019;21(2):121-124. (In Russ.) https://doi.org/10.15825/1995-1191-2019-2-121-124
Views:
900
Email this article 